4.6 Article

Carbonic anhydrases in meningiomas: association of endothelial carbonic anhydrase II with aggressive tumor features Laboratory investigation

期刊

JOURNAL OF NEUROSURGERY
卷 111, 期 3, 页码 472-477

出版社

AMER ASSOC NEUROLOGICAL SURGEONS
DOI: 10.3171/2008.10.17672

关键词

cancer; carbonic anhydrase; immunohistochemistry; meningioma; tissue microarray

资金

  1. Cancer Society of Finland
  2. Academy of Finland
  3. EU
  4. Medical Research Fund of Tampere University Hospital

向作者/读者索取更多资源

Object. Carbonic anhydrase (CA) II and IX are enzymes involved in pH homeostasis and have been shown to be upregulated in several types of cancer. In this Study, the authors evaluate the expression of CA II and IX in meningiomas and assess their relationship to patient age, tumor type and grade, tumor sex hormone receptor status. tumor cell proliferation, and tumor recurrence. Methods. This study was conducted in consecutive patients who underwent meningioma surgeries at Tampere University Hospital between 1989 and 1999. The expression of CA II and IX was studied immunohistochemically using a tissue microarray technique and specific antibodies. Results. Immunohistological staining with CA II and IX was assessed in 443 primary and 67 recurrent tumor specimens. Of these samples, 455 were benign (WHO Grade I), 49 atypical (Grade II), and 6 malignant (Grade III). Endothelial cells in 14.8% of the tumors stained positively for CA II. Tumor cells were positive for CA IX in 11.6% of the cases. Endothelial CA H expression correlated with increasing histological grade (p = 0.002), and tumor proliferation rates were higher in CA II+ versus CA II- cases (p = 0.002). Androgen receptor-negative tumors were found to be CA II+ significantly more often than androgen receptor-positive tumors (p = 0.001). No associations were found with the CA IX enzyme. Conclusions. Carbonic anhydrase II positivity in the endothelium was associated with cell proliferation and malignancy grade. These results Suggest that CA II expression is associated with malignant progression of meningiomas and could thus be a target molecule for anticancer therapy. (DOI: 10.3171/2008.10.17672)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据